We are live on ! Find out more
RCPI

ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI

Delisted

RCPI was delisted on the 4th of November, 2015.

Back to rankings

2 hedge funds and large institutions have $5 invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MAM
Meeder Asset Management
Ohio
+$4
2
SA
Scarborough Advisors
Maryland
+$1

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
1
Meeder Asset Management
Ohio
$4 +$4 +40,000 New
SA
2
Scarborough Advisors
Maryland
$1 +$1 +10,000 New

RCPI Hedge Fund Activity: Q1 2023 in Review

2 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q1 2023, worth a combined $5.

Buyers outnumbered sellers: 2 funds opened new RCPI positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Meeder Asset Management, opening a new position worth an estimated $4.

  • 2 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q1 2023, up from 0 in Q4 2022.
  • Funds reported $5 of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q1 2023.
  • 2 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q1 2023 and 0 closed out, a net change of +2 holders.
  • The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2023 was Meeder Asset Management, an estimated $4 added.

Based on aggregated 13F filings for Q1 2023.